PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Peroxisome proliferator-activated receptors (PPARs) are nuclear receptors that regulate lipid and glucose metabolism and cellular differentiation. PPAR-alpha and PPAR-gamma are both expressed in human macrophages where they exert anti-inflammatory effects. The activation of PPAR-alpha may promote foam-cell formation by inducing expression of the macrophage scavenger receptor CD36. This prompted us to investigate the influence of different PPAR-activators on cholesterol metabolism and foam-cell formation of human primary and THP-1 macrophages. Here we show that PPAR-alpha and PPAR-gamma activators do not influence acetylated low density lipoprotein-induced foam-cell formation of human macrophages. In contrast, PPAR-alpha and PPAR-gamma activators induce the expression of the gene encoding ABCA1, a transporter that controls apoAI-mediated cholesterol efflux from macrophages. These effects are likely due to enhanced expression of liver-x-receptor alpha, an oxysterol-activated nuclear receptor which induces ABCA1-promoter transcription. Moreover, PPAR-alpha and PPAR-gamma activators increase apoAI-induced cholesterol efflux from normal macrophages. In contrast, PPAR-alpha or PPAR-gamma activation does not influence cholesterol efflux from macrophages isolated from patients with Tangier disease, which is due to a genetic defect in ABCA1. Here we identify a regulatory role for PPAR-alpha and PPAR-gamma in the first steps of the reverse-cholesterol-transport pathway through the activation of ABCA1-mediated cholesterol efflux in human macrophages.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This mechanism is pivotal in controlling intracellular lipid content and serves as a primary “gatekeeper” for reverse cholesterol transport in cells [23].”
From miR-223 accelerates lipid droplets clearance in microglia following spinal cord injury by upregulating ABCA1 (2024) · cites this paper as [23]
In the citing paper
“The activation of PPARα also accelerates reverse cholesterol transport (RCT) via increased expression of ABCA1 and ABCG1 transporters involved in cholesterol efflux from macrophages [29, 40].”
From Pemafibrate, a new selective PPARα modulator: drug concept and its clinical applications for dyslipidemia and metabolic diseases (2020) · cites this paper as [40]
Citations
Cites
A SIMPLE METHOD FOR THE ISOLATION AND PURIFICATION OF TOTAL LIPIDES FROM ANIMAL TISSUES
Folch, J., Lees, M., & Stanley, G. H. S. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64849-5 · Cited by 65,189
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630 · cited 1×
“, and this led to the suggestion that PPAR-activators may modulate foam-cell formation, a known atherogenic process characterized by cholesteryl-ester-droplet accumulation in the cytoplasm of macrophage”
BackgroundThe peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., & Glass, C. K. (1998) · Nature · doi:10.1038/34178 · Cited by 3,525
Rubins, H. B., Robins, S. J., Collins, D., Fye, C. L., Anderson, J. W., Elam, M. B., Faas, F. H., Linares, E., Schaefer, E. J., Schectman, G., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908053410604 · Cited by 3,439
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
Jiang, C., Ting, A. T., & Seed, B. (1998) · Nature · doi:10.1038/34184 · Cited by 2,899 · cited 1×
“Both PPAR-α and PPAR-γ are expressed in fully-differentiated human macrophages where they regulate genes implicated in the inflammatory response, modulate macrophage differentiation and promote TNF-α/IFN-γ–induced apoptosi”
BackgroundThe PPARs: From Orphan Receptors to Drug Discovery
Willson, T. M., Brown, P. J., Sternbach, D. D., & Henke, B. R. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990554g · Cited by 1,816 · cited 1×
“We treated these cells with either the PPAR-α ligand Wy14643 or the PPAR-γ ligand rosiglitazone at concentrations of 2–3 times their EC 50 values (Wy14643 EC 50 for human PPAR-αe25 μM and rosiglitazone EC 50 for human PPAR-γe43 nM”
PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL
Tontonoz, P., Nagy, L., Alvarez, J. G. A., Thomazy, V. A., & Evans, R. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81575-5 · Cited by 1,797 · cited 1×
“Moreover, PPAR-α activation results in the transcriptional induction of CD36 expression in macrophage”
BackgroundMechanism of Action of Fibrates on Lipid and Lipoprotein Metabolism
Staels, B., Dallongeville, J., Auwerx, J., Schoonjans, K., Leitersdorf, E., & Fruchart, J.-C. (1998) · Circulation · doi:10.1161/01.cir.98.19.2088 · Cited by 1,786 · cited 1×
“The stimulatory role of PPAR-α activators on hepatic HDL production and apoAI expression is well-documente”
BackgroundSelf-citationMutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
Brooks-Wilson, A., Marcil, M., Clee, S. M., Zhang, L.-H., Roomp, K., van Dam, M., Yu, L., Brewer, C., Collins, J. A., Molhuizen, H. O. F., et al. (1999) · Nature Genetics · doi:10.1038/11905 · Cited by 1,687
An oxysterol signalling pathway mediated by the nuclear receptor LXRα
Janowski, B. A., Willy, P. J., Devi, T. R., Falck, J. R., & Mangelsdorf, D. J. (1996) · Nature · doi:10.1038/383728a0 · Cited by 1,591 · cited 1×
“We also show that both PPAR-α and PPAR-γ activators induce ABCA1 expression, possibly through their inductive effects on expression of LXR-α, a nuclear receptor activated by oxysterol”
Background
Cited by
Items 401–500 of 1,000
Identification and regulation of novel PPAR-γ splice variants in human THP-1 macrophages
Chen, Y., Jimenez, A. R., & Medh, J. D. (2006) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/j.bbaexp.2006.01.005 · Cited by 71
Peroxisome proliferator‐activated receptors in cardiac energy metabolism and cardiovascular disease
Ajith, T. A., & Jayakumar, T. G. (2016) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12579 · Cited by 58
“TZDs was also effective to increase the HDL-C and reduce the TAG level.(64,65) Despite the antidiabetic activity, a recent study among the TZDs treated type II diabetic patients did not show any significant decline of morbidity or mortality from the complications of CVD.”
BackgroundMitochondrial regulation of macrophage cholesterol homeostasis
Graham, A. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.08.010 · Cited by 58
Nakaya, K., Tohyama, J., Naik, S. U., Tanigawa, H., MacPhee, C., Billheimer, J. T., & Rader, D. J. (2011) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.225383 · Cited by 55
Waltmann, M. D., Basford, J. E., Konaniah, E. S., Weintraub, N. L., & Hui, D. Y. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.05.009 · Cited by 60
Jia, Y., Qi, C., Zhang, Z., Hashimoto, T., Rao, M. S., Huyghe, S., Suzuki, Y., Van Veldhoven, P. P., Baes, M., & Reddy, J. K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306363200 · Cited by 55
Zhou, J., Wilson, K. M., & Medh, J. D. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00138-9 · Cited by 69
“Reports from different investigators over the past few years have ascertained that PPAR-γ activation leads to the modulation of several genes, some of which have opposing functions [4,7,11,22].”
BackgroundResultInfluentialLaminar Shear Stress Regulates Liver X Receptor in Vascular Endothelial Cells
Zhu, M., Fu, Y., Hou, Y., Wang, N., Guan, Y., Tang, C., Shyy, J. Y.-J., & Zhu, Y. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.143487 · Cited by 54
Galindo, C. L., Khan, S. R., Zhang, X., Yeh, Y., Liu, Z., & Razani, B. (2023) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2023.2288272 · Cited by 61
Hontecillas, R., Diguardo, M., Duran, E., Orpí, M., & Bassaganya-Riera, J. (2008) · Clinical Nutrition · doi:10.1016/j.clnu.2008.07.007 · Cited by 58
Zhang, L., Kamanna, V. S., Ganji, S. H., Xiong, X., & Kashyap, M. L. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m020917 · Cited by 57
AMPK activates LXRα and ABCA1 expression in human macrophages
Kemmerer, M., Wittig, I., Richter, F. M., Brüne, B., & Namgaladze, D. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.06.014 · Cited by 53
Resveratrol inhibits lipid accumulation in the intestine of atherosclerotic mice and macrophages
Ye, G., Chen, G., Gao, H., Lin, Y., Liao, X., Zhang, H., Liu, X., Chi, Y., Huang, Q., Zhu, H., et al. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14323 · Cited by 57
Seber, S., Uçak, S., Basat, O., & Altuntaş, Y. (2005) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2005.05.009 · Cited by 53
Rival, Y., Stennevin, A., Puech, L., Rouquette, A., Cathala, C., Lestienne, F., Dupont-Passelaigue, E., Patoiseau, J., Wurch, T., & Junquero, D. C. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.068254 · Cited by 58
“467 at A SPE T Journals on A ugust 19, 2017 jpet.aspetjournals.org nloaded from cholesterol efflux from peripheral tissues and the high-density lipoprotein reverse cholesterol-transport pathway (Chinetti et al., 2001).”
BackgroundRegulation of ABCA1 expression in human keratinocytes and murine epidermis
Jiang, Y. J., Lu, B., Kim, P., Elias, P. M., & Feingold, K. R. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m600163-jlr200 · Cited by 53
Bricarello, L. P., Kasinski, N., Bertolami, M. C., Faludi, A. Á., Pinto, L. E. S. A., Relvas, W. G. M., Izar, M. C. D. O., Ihara, S. S. M., Tufik, S., & Fonseca, F. A. H. (2004) · Nutrition · doi:10.1016/j.nut.2003.10.005 · Cited by 57
Marx, N., Libby, P., & Plutzky, J. (2001) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/174182670100800404 · Cited by 61
Lazar, M. A. (2002) · Genes & Development · doi:10.1101/gad.964002 · Cited by 59
“In macrophages, PPAR ligands inhibit cytokine gene expression (Jiang et al. 1998; Ricote et al. 1998) and induce the expression of another nuclear receptor, LXR, that enhances the expression of ABC reverse cholesterol transporters (Repa et al. 2000; Chawla et al. 2001b; Chinetti et al. 2001).”
BackgroundMeCP2 Is an Epigenetic Factor That Links DNA Methylation with Brain Metabolism
Vuu, Y. M., Roberts, C.-T., & Rastegar, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044218 · Cited by 61
An Integrated Biological Approach to Nuclear Receptor Signaling in Physiological Control and Disease
Carlberg, C., & Dunlop, T. W. (2006) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v16.i1.10 · Cited by 57
Reduction of Atherosclerotic Plaques by Lysosomal Acid Lipase Supplementation
Du, H., Schiavi, S. C., Wan, N. C., Levine, M., Witte, D. P., & Grabowski, G. A. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000107030.22053.1e · Cited by 54
Ciffolilli, S., Wallert, M., Bartolini, D., Krauth, V., Werz, O., Piroddi, M., Sebastiani, B., Torquato, P., Stefan Lorkowski, A., Birringer, M., et al. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.08.019 · Cited by 51
Anti-atherosclerotic potential of gossypetin via inhibiting LDL oxidation and foam cell formation
Chen, J., Tsai, C.-W., Wang, C.-P., & Lin, H. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.06.027 · Cited by 54
Bouhlel, M. A., Staels, B., & Chinetti‐Gbaguidi, G. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01892.x · Cited by 51
Self-citationFish Oil Promotes Macrophage Reverse Cholesterol Transport in Mice
Nishimoto, T., Pellizzon, M. A., Aihara, M., Stylianou, I. M., Billheimer, J. T., Rothblat, G., & Rader, D. J. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.187252 · Cited by 51
Carmona, M. C., Louche, K., Lefebvre, B., Pilon, A., Hennuyer, N., Audinot-Bouchez, V., Fievet, C., Torpier, G., Formstecher, P., Renard, P., et al. (2007) · Diabetes · doi:10.2337/db06-1734 · Cited by 51
Self-citationPiperine inhibits ABCA1 degradation and promotes cholesterol efflux from THP‐1‐derived macrophages
Wang, L., Palme, V., Rotter, S., Schilcher, N., Cukaj, M., Wang, D., Ladurner, A., Heiß, E. H., Stangl, H., Dirsch, V. M., et al. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500960 · Cited by 52
Hodgkinson, C. P., & Ye, S. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01416-5 · Cited by 51
Comparison of the effects of pioglitazone and rosiglitazone on macrophage foam cell formation
Hirakata, M., Tozawa, R., Imura, Y., & Sugiyama, Y. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.08.151 · Cited by 57
Li, L., Beauchamp, M.-C., & Renier, G. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(02)00203-4 · Cited by 59
Cyclic AMP-Specific Phosphodiesterase 4 Inhibitors Promote ABCA1 Expression and Cholesterol Efflux
Lin, G., & Bornfeldt, K. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6259 · Cited by 55
Соболев, В. В., Tchepourina, E., Korsunskaya, I. M., Geppe, N. A., Chebysheva, S. N., Соболева, А. Г., & Mezentsev, A. V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179708 · Cited by 57
Mueller, M., Hobiger, S., & Jungbauer, A. (2010) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3181c94617 · Cited by 55
Aspirin increases CD36, SR-BI, and ABCA1 expression in human THP-1 macrophages
Viñals, M. L., Bermúdez-Escobar, I. C., Llaverías, G., Alegret, M., SANCHEZ, R., Vázquez‐Carrera, M., & Laguna, J. C. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.12.024 · Cited by 55
Le Goff, W., Zheng, P., Brubaker, G., & Smith, J. D. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000201042.00725.84 · Cited by 50
Kämmerer, I., Ringseis, R., Biemann, R., Wen, G., & Eder, K. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-222 · Cited by 56
“In addition, synthetic PPARg agonists were reported to stimulate macrophage cholesterol efflux by the same mechanisms as PPARa agonists, namely through activating the PPAR-LXR-pathway [12].”
Shen, Z., Chen, X.-Q., Sun, X., Sun, J., Zhang, W., Zheng, X., Zhang, Y.-Y., Shi, H., Zhang, J., Li, C., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.739243 · Cited by 55
“PPARγ also directly regulates LXRα and a PPARγ-LXR-ABCA1 pathway has been proposed (30,31).”
BackgroundTutunchi, H., Ostadrahimi, A., Saghafi‐Asl, M., & Maleki, V. (2019) · Obesity Reviews · doi:10.1111/obr.12853 · Cited by 54
Peroxisome Proliferator-Activated Receptors and the Cardiovascular System
Chen, Y. E., Fu, M., Zhang, J., Zhu, X., Lin, Y., Akinbami, M. A., & Song, Q. (2003) · Vitamins and hormones · doi:10.1016/s0083-6729(03)01005-7 · Cited by 53
Peroxisome Proliferator-Activated Receptors and Liver X Receptors in Atherosclerosis and Immunity
Barish, G. D. (2006) · Journal of Nutrition · doi:10.1093/jn/136.3.690 · Cited by 57
Cytokine imbalance in acute coronary syndrome
Alam, S., Nasser, S., Fernainy, K. E., Habib, A. A., & Badr, K. F. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2003.10.011 · Cited by 55
Molecular mechanisms and genetic regulation in atherosclerosis
Jackson, A. O., Regine, M. A., Chakrabarti, S., & Long, S. (2018) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2018.09.006 · Cited by 55
Sandberg, M. B., Bloksgaard, M., Durán-Sandoval, D., Duval, C., Staels, B., & Mandrup, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407515200 · Cited by 59
Self-citationNishimukai, M., Maeba, R., Yamazaki, Y., Nezu, T., Sakurai, T., Takahashi, Y., Hui, S., Chiba, H., Okazaki, T., & Hara, H. (2014) · Journal of Lipid Research · doi:10.1194/jlr.p045591 · Cited by 53
Zhao, S., Yang, J., Li, J., Dong, S.-Z., & Wu, Z. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.12.032 · Cited by 56
A new insight into the treatment of diabetes by means of pan PPAR agonists
Chandra, A., Kaur, P., Sahu, S. K., & Mittal, A. (2022) · Chemical Biology & Drug Design · doi:10.1111/cbdd.14020 · Cited by 50
“Moreover, PPARγ agonists tend to provoke reverse cholesterol transport (Chawla et al., 2001; Chinetti et al., 2001) and have proven to have advantageous effects on the low HDL- cholesterol levels and elevated triglyceride levels that help managing diabetic dyslipidaemia.”
BackgroundAlbrecht, C., Simon-Vermot, I., Elliott, J. I., Higgins, C. F., Johnston, D. G., & Valabhji, J. (2003) · Metabolism · doi:10.1016/j.metabol.2003.07.009 · Cited by 50
PPARs in atherosclerosis: the clot thickens
Castrillo, A., & Tontonoz, P. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200423705 · Cited by 48
Bingham, T. C., Fisher, E. A. A., Parathath, S., Reiss, A. B., Chan, E. S. L., & Cronstein, B. N. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0709513 · Cited by 48
“Interestingly, in contrast to prior studies in injury-induced models of atherosclerosis [13], recent studies about atherosclerosis-prone apoE-deficient mice lacking A2ARs suggest that loss of A2ARs prevents the development of atherosclerosis [15].”
ResultHesperetin Upregulates ABCA1 Expression and Promotes Cholesterol Efflux from THP-1 Macrophages
Iio, A., Ohguchi, K., Iinuma, M., Nozawa, Y., & Ito, M. (2012) · Journal of Natural Products · doi:10.1021/np200696r · Cited by 53
Peroxisome proliferator-activated receptors: are they involved in atherosclerosis progression?
Puddu, P., Puddu, G. M., & Muscari, A. (2003) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00565-x · Cited by 51
Sanni, O., Erukainure, O. L., Chukwuma, C. I., Koorbanally, N. A., Ibeji, C. U., & Islam, M. S. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.171 · Cited by 57
Dietary fatty acids and the haemostatic system
Miller, G. J. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.10.010 · Cited by 48
Kappert, K., Tsuprykov, O., Kaufmann, J., Fritzsche, J., Ott, I., Goebel, M., Bähr, I. N., Häßle, P.-L., Gust, R., Fleck, E., et al. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.132886 · Cited by 50
Zadelaar, A. S. M., Boesten, L. S. M., Jukema, J. W., van Vlijmen, B. J. M., Kooistra, T., EMEIS, J. J., Lundholm, E., Camejo, G., & Havekes, L. M. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000242904.34700.66 · Cited by 48
CD36 deficiency induced by antiretroviral therapy
Serghides, L., Nathoo, S., Walmsley, S. L., & Kain, K. C. (2002) · AIDS · doi:10.1097/00002030-200202150-00006 · Cited by 48
Caveolae and Caveolin-1 Integrate Reverse Cholesterol Transport and Inflammation in Atherosclerosis
Qin, L., Zhu, N., Ao, B.-X., Liu, C., Shi, Y.-N., Du, K., Chen, J.-X., Zheng, X.-L., & Liao, D.-F. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17030429 · Cited by 46
“Moreover, the coactivator thyroid hormone receptor-associated protein 80 specifically activates SREBP-1c [67].”
BackgroundPleiotropic effects of fibrates
Chinetti, G., Fruchart, J., & Staels, B. (2005) · Current Atherosclerosis Reports · doi:10.1007/s11883-005-0053-x · Cited by 51
Self-citationZhou, Q., Mei, Y., Shoji, T., Han, X., Kamiński, K. A., Oh, G. T., Ongusaha, P. P., Zhang, K., Schmitt, H., Moser, M., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.086041 · Cited by 48
Cruz-Garcia, L., Saera-Vila, A., Navarro, I., Calduch-Giner, J. À., & Pérez‐Sánchez, J. (2009) · Journal of Experimental Biology · doi:10.1242/jeb.029025 · Cited by 48
A review on potential therapeutic properties of Pomegranate (Punica granatum L.)
Puneeth, H. R., & Chandra, S. (2020) · Plant Science Today · doi:10.14719/pst.2020.7.1.619 · Cited by 60
Cabrero, À., Cubero, M., Llaverı́as, G., Alegret, M., Sánchez, R., Laguna, J. C., & Vázquez‐Carrera, M. (2005) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-005-1353-8 · Cited by 45
“This gene, which is regulated by PPARγ [4], controls the entry of fatty acids into the mitochondria, where they are oxidized.”
BackgroundInfluentialHepatic Peroxisomal Fatty Acid β-Oxidation Is Regulated by Liver X Receptor α
Hu, T., Foxworthy, P., Siesky, A., Ficorilli, J. V., Gao, H., Li, S., Christe, M., Ryan, T., Cao, G., Eacho, P., et al. (2005) · Endocrinology · doi:10.1210/en.2005-0591 · Cited by 45
Johnstone, C. N., Mongroo, P. S., Rich, A. S., Schupp, M., Bowser, M., deLemos, A. S., Tobias, J. W., Liu, Y., Hannigan, G. E., & Rustgi, A. K. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01617-06 · Cited by 44
Gao, J., Xu, Y., Yang, Y., Yang, Y., Zheng, Z., Jiang, W., Hong, B., Yan, X., & Si, S. (2008) · SLAS DISCOVERY · doi:10.1177/1087057108320545 · Cited by 47
Beyer, T. P., Schmidt, R. J., FOXWORTHY, P. S., Zhang, Y., Dai, J., Bensch, W. R., Kauffman, R. F., Gao, H. T., Ryan, T. P., Jiang, X., et al. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.064535 · Cited by 45
Luo, S., Huang, Y., Xie, F., Huang, X., Liu, Y., Wang, W.-N., & Qin, Q. (2015) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2015.01.003 · Cited by 45
Feeney, E. R., McAuley, N., O’Halloran, J. A., Rock, C., Low, J., Satchell, C. S., Lambert, J. S., Sheehan, G. J., & Mallon, P. W. G. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis723 · Cited by 49
Intestinal PPARδ protects against diet-induced obesity, insulin resistance and dyslipidemia
Doktorova, M., Zwarts, I., van Zutphen, T., van Dijk, T. H., Bloks, V. W., Harkema, L., de Bruin, A., Downes, M., Evans, R. M., Verkade, H. J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-00889-z · Cited by 48
Kotlyarov, S. N., & Bulgakov, A. (2021) · Cells · doi:10.3390/cells10112978 · Cited by 49
Cabrero, À., Cubero, M., Llaverías, G., Jové, M., Planavila, A., Alegret, M., Sánchez, R., Laguna, J. C., & Vázquez‐Carrera, M. (2003) · Metabolism · doi:10.1053/meta.2003.50100 · Cited by 44
Inhibitory Effects of Grape Seed Procyanidins on Foam Cell Formation in Vitro
Terra, X., Fernández-Larrea, J., Pujadas, G., Ardèvol, A., Bladé, C., Salvadó, M. J., Arola, L., & Blay, M. (2009) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf803450a · Cited by 43
Nuclear receptors, cholesterol homeostasis and the immune system
Shahoei, S. H., & Nelson, E. R. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.04.013 · Cited by 43
Drug Insight: thiazolidinediones and diabetic nephropathy—relevance to renoprotection
Panchapakesan, U., Chen, X., & Pollock, C. A. (2005) · Nature Reviews Nephrology · doi:10.1038/ncpneph0029 · Cited by 45
Fu, M., Zhu, X., Wang, Q., Zhang, J., Song, Q., Zheng, H., Ogawa, W., Du, J., & Chen, Y. E. (2001) · Circulation Research · doi:10.1161/hh2301.099642 · Cited by 44
Atherothrombosis: Plaque instability and thrombogenesis
Ruberg, F. L., Leopold, J. A., & Loscalzo, J. (2002) · Progress in Cardiovascular Diseases · doi:10.1053/pcad.2002.123469 · Cited by 47
Gervois, P. P., Fruchart, J., & Staels, B. (2004) · International Journal of Clinical Practice · doi:10.1111/j.1368-504x.2004.00376.x · Cited by 48
Self-citationCardiac-specific ablation of ARNT leads to lipotoxicity and cardiomyopathy
Wu, R., Chang, H., Khechaduri, A., Chawla, K., Tran, M., Chai, X., Wagg, C. S., Ghanefar, M., Jiang, X., Bayeva, M., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci76737 · Cited by 44
Microglial Phagocytosis—Rational but Challenging Therapeutic Target in Multiple Sclerosis
Pinto, M. V., & Fernandes, A. M. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21175960 · Cited by 45
Ran, Y. I. N., Dong, Y., & Li, H. (2006) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2006.00359.x · Cited by 46
Expression, regulation, and activity of ABCA1 in human cell lines
Denis, M., Bissonnette, R., Haidar, B., Krimbou, L., Bouvier, M., & Genest, J. J. (2003) · Molecular Genetics and Metabolism · doi:10.1016/s1096-7192(03)00020-9 · Cited by 53
Roy, P. K., Islam, J., & Lalhlenmawia, H. (2023) · The Egyptian Heart Journal · doi:10.1186/s43044-023-00352-7 · Cited by 56
Capobianco, E., Martínez, N., Fornes, D. D., Higa, R., Marco, I. D., Basualdo, M. N., Faingold, M. C., & Jawerbaum, A. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.06.027 · Cited by 45
Iio, A., Ohguchi, K., Maruyama, H., Tazawa, S., Araki, Y., Ichihara, K., Nozawa, Y., & Ito, M. (2012) · Phytomedicine · doi:10.1016/j.phymed.2011.10.007 · Cited by 72
Stylianou, I. M., Affourtit, J. P., Shockley, K. R., Wilpan, R. Y., Abdi, F. A., Bhardwaj, S., Rollins, J. A., Churchill, G. A., & Paigen, B. J. (2008) · Genetics · doi:10.1534/genetics.107.081216 · Cited by 47
Xu, X., Guo, H., Zuo, J. L., Yang, L., Chen, C., Lu, P., Wang, X., Lu, Y., Ye, R., Jin, X., et al. (2016) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000413 · Cited by 43
Ren, T., Zhu, J., Zhu, L., & Cheng, M. (2017) · Nutrients · doi:10.3390/nu9030198 · Cited by 47
Nishimaki‐Mogami, T., Tamehiro, N., Sato, Y., Okuhira, K., Sai, K., Kagechika, H., Shudo, K., Abe-Dohmae, S., Yokoyama, S., Ohno, Y., et al. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.08.005 · Cited by 44
Enzymology and Molecular Biology of Glucocorticoid Metabolism in Humans
Blum, A., & Maser, E. (2003) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(03)75006-5 · Cited by 48
Gilde, A. J., Fruchart, J., & Staels, B. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.04.097 · Cited by 49
Self-citationWang, Y., Wang, Y., Yang, Q., Yan, J., Zhao, C., Cianflone, K., & Wang, D. W. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.09.008 · Cited by 43
Investigational PPAR-γ agonists for the treatment of Type 2 diabetes
Savkur, R. S., & Miller, A. R. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.7.763 · Cited by 43
“CHINETTI G, LESTAVEL S, BOCHER V et al.: PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway.”
BackgroundThiazolidinediones and risk for atherosclerosis: pleiotropic effects of PPARγ agonism
Patle, C. B., de Lemos, J. A., Wyne, K. L., & McGuire, D. K. (2006) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2006.016 · Cited by 41
Ringseis, R., Wen, G., Saal, D., & Eder, K. (2008) · Lipids · doi:10.1007/s11745-008-3226-x · Cited by 40
Orfila, C., Lepert, J., Alric, L., Carrera, G., Béraud, M., & Pipy, B. (2005) · Histochemistry and Cell Biology · doi:10.1007/s00418-005-0785-2 · Cited by 43
“PPARa and PPARc exert anti-inflammatory effects in macrophages (Chinetti et al. 2001).”
BackgroundFinkelstein, J. M., Heemels, M.-T., Shadan, S., & Weiss, U. K. (2014) · Nature · doi:10.1038/510047a · Cited by 44
Paciello, F., Pisani, A., Rolesi, R., Escarrat, V., Galli, J., Paludetti, G., Grassi, C., Troiani, D., & Fetoni, A. R. (2021) · Antioxidants · doi:10.3390/antiox10081188 · Cited by 43
Yamashita, S., Rizzo, M., Su, T., & Masuda, D. (2023) · Metabolites · doi:10.3390/metabo13050626 · Cited by 44
“PPARα activation increases the gene expression of ABCA1 and ABCG1, which accelerates the efflux of cholesterol from macrophages [27].”
BackgroundSingh, A., & Chaudhary, R. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114616 · Cited by 44
Metadata
- Authors
- Chinetti, G., Lestavel, S., Bocher, V., Remaley, A. T., Neve, B., Torra, I. P., Teissier, E., Minnich, A., Jaye, M., Duverger, N., Brewer, H. B., Fruchart, J.-C., Clavey, V., & Staels, B.
- Affiliations
- Inserm (FR)
- National Institutes of Health (US)
- Sanofi (France) (FR)
- Corresponding author
- Staels, Bart
- Venue
- Nature Medicine
- Published
- 2001-01
- Volume
- 7
- Issue
- 1
- Pages
- 53-58
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1524478189
- Cited by
- 1,170
- References
- 39
- Citations by year
- 2026: 12 · 2025: 29 · 2024: 31 · 2023: 41 · 2022: 25 · 2021: 28 · 2020: 30 · 2019: 20 · 2018: 29 · 2017: 31 · 2016: 38 · 2015: 33 · 2014: 50 · 2013: 37 · 2012: 38
- FWCI
- 99.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Paraoxonase enzyme and polymorphisms
- Keywords
- PPARα, PPARγ, ABCA1, cholesterol efflux, foam cells, macrophages, reverse cholesterol transport, liver X receptor alpha, apolipoprotein A-I, Tangier disease, acetylated LDL, CD36, THP-1 macrophages
- MeSH terms
- Base Sequence, Biological Transport, Cells, Cultured, Cholesterol, Foam Cells, Humans, Transcription Factors, DNA Primers, Receptors, Cytoplasmic and Nuclear, ATP-Binding Cassette Transporters, ATP Binding Cassette Transporter 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.